Bacterial metabolites trimethylamine N-oxide and butyrate as surrogates of small intestinal bacterial overgrowth in patients with a recent decompensated heart failure
Abstract In patients with heart failure (HF), the exhaled concentrations of hydrogen after a breath test—a non-invasive assessment of small intestinal overgrowth- has been related to HF severity and higher risk of adverse outcomes. Indeed, two intestinal bacterial metabolites—blood Trimethylamine N-...
Guardado en:
Autores principales: | Anna Mollar, Vannina G. Marrachelli, Eduardo Núñez, Daniel Monleon, Vicent Bodí, Juan Sanchis, David Navarro, Julio Núñez |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/cce0c779f69146fe855347fb475f4017 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Small Intestine Bacterial Overgrowth and Environmental Enteropathy in Bangladeshi Children
por: Jeffrey R. Donowitz, et al.
Publicado: (2016) -
Small Intestinal Bacterial Overgrowth as Potential Therapeutic Target in Parkinson’s Disease
por: Adela Dănău, et al.
Publicado: (2021) -
Revealing the Bacterial Butyrate Synthesis Pathways by Analyzing (Meta)genomic Data
por: Marius Vital, et al.
Publicado: (2014) -
Gut Metabolite Trimethylamine-N-Oxide in Atherosclerosis: From Mechanism to Therapy
por: BingYu Wang, et al.
Publicado: (2021) -
Optically-controlled bacterial metabolite for cancer therapy
por: Di-Wei Zheng, et al.
Publicado: (2018)